Rhabdomyolysis Evaluation and Emergent Management

Emergency Medicine

Volumn 44, Issue 1, 2012, Pages 11-16

  Desai, Bobby ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855867199     PISSN: 00136654     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve., 2002;25(3):332-347.
2. Slater MS, Mullins RJ. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg., 1998;186(6):693-716.
3. Tonin P, Lewis P, Servidei S, DiMauro S. Metabolic causes of myoglobinuria. Ann Neurol., 1990;27(2):181-185.
4. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis--an overview for clinicians. Crit Care., 2005;9(2):158-169.
5. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med., 2009;361(1):62-72.
6. Grossman RA, Hamilton RW, Morse BM, et al. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med., 1974;291(16):807-811.
7. Fernandez WG, Hung O, Bruno GR, et al. Factors predictive of acute renal failure and need for hemodialysis among ED patients with rhabdomyolysis. Am J Emerg Med., 2005;23(1):1-7.
8. Mohaupt MG. Rhabdomyolysis [in German]. Ther Umsch., 2003;60(7):391-397.
9. Deighan CJ, Wong KM, McLaughlin KJ, Harden P. Rhabdomyolysis and acute renal failure resulting from alcohol and drug abuse. QJM., 2000;93(1):29-33.
10. Chang JT, Staffa JA, Parks M, Green L. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Pharmacoepidemiol Drug Saf., 2004;13(7):417-426.
11. Welch RD, Todd K, Krause GS. Incidence of cocaine-associated rhabdomyolysis. Ann Emerg Med., 1991;20(2):154-157.
12. Crowe AV, Howse M, Bell GM, Henry JA. Substance abuse and the kidney. QJM., 2000;93(3):147-152.
13. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int., 1996;49(2):314-326.
14. Hubbard RW. Heatstroke pathophysiology: the energy depletion model. Med Sci Sports Exerc. 1990;22(1):19-28.
15. Loke J, MacLennan DH. Malignant hyperthermia and central core disease: disorders of Ca2+ release channels. Am J Med., 1998;104(5):470-486.
16. Kasamatsu Y, Osada M, Ashida K, et al. Rhabdomyolysis after infection and taking a cold medicine in a patient who was susceptible to malignant hyperthermia. Intern Med., 1998;37(2):169-173.
17. Anetseder M, Hartung E, Klepper S, Reichmann H. Gasoline vapors induce severe rhabdomyolysis. Neurology., 1994;44(12):2393-2395.
18. Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis., 2007;2:21.
19. Britt BA. Malignant hyperthermia. In: Lane RJM, ed. Handbook of Muscle Diseases., New York, NY: Marcel Dekker; 1996:451-457.
20. Kornhuber J, Weller M. Neuroleptic malignant syndrome. Curr Opin Neurol., 1994;7(4):353-357.
21. Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-induced serotonin-syndrome: a review. Expert Opin Drug Saf., 2008;7(5):587-596.
22. Miller F, Friedman R, Tanenbaum J, Griffin A. Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome. J Clin Psychopharmacol., 1991;11(4):277-279.
23. Knochel JP. Catastrophic medical events with exhaustive exercise: "white collar rhabdomyolysis. " Kidney Int., 1990;38(4):709-719.
24. Schiff H, MacSearraigh E, Kallmeyer J. Myoglobinuria, rhabdomyolysis and marathon running. Q J Med., 1978;47(188):463-472.
25. Schwaber MJ, Liss HP, Steiner I, Brezis M. Hazard of sauna after strenuous exercise. Ann Intern Med., 1994;120(5):441-442.
26. Poels P, Gabreëls F. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg., 1995;95(3):175-192.
27. Rosen C, Adler J, Rabban J, et al. Early predictors of myoglobinuria and acute renal failure following electrical injury. J Emerg Med., 1999;17(5):783-789.
28. Smith J, Greaves I. Crush injury and crush syndrome: a review. J Trauma., 2003;54(5 suppl):S226-S230.
29. Cockburn M, Namias, N. Complications of electrical injury. In: Complications in Surgery and Trauma., Cohn SM, ed. Philadelphia, PA: Lippincott-Raven; 1997:535-536.
30. Brumback R, Feeback D, Leech R. Rhabdomyolysis following electrical injury. Semin Neurol., 1995;15(4):329-334.
31. Shintani S, Shiigai T, Tsukagoshi H. Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment. Eur Neurol., 1991;31(6):396-398.
32. Fukada Y, Ohta S, Mizuno K, Hoshi K. Rhabdomyolysis secondary to hyperemesis gravidarum. Acta Obstet Gynecol Scand., 1999;78(1):71.
33. Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis., 1996;22(4):642-649.
34. Armstrong JH. Tropical pyomyositis and myoglobinuria. Arch Intern Med., 1978;138(7):1145-1146.
35. Karadimas CL, Greenstein P, Sue CM, et al. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA. Neurology., 2000;55(5):644-649.
36. Brumback RA, Feeback DL, Leech RW. Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production. Pediatr Clin North Am. 1992;39(4):821-858.
37. Ng YT, Johnston HM. Clinical rhabdomyolysis. J Paediatr Child Health., 2000;36(4):397-400.
38. Richards JR. Rhabdomyolysis and drugs of abuse. J Emerg Med., 2000;19(1):51-56.
39. Al-Ismaili Z, Piccioni M, Zappitelli M. Rhabdomyolysis: pathogenesis of renal injury and management. Pediatr Nephrol., 2011;26(10):1781-1788.
40. Akmal M, Massry SG. Reversible hepatic dysfunction associated with rhabdomyolysis. Am J Nephrol. 1990;10(1):49-52.
41. Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics., 2006;118(5):2119-2125.
42. Mann SC, Caroff SN, Fricchione GE, Campbell EC. Central dopamine hypoactivity and the pathogenesis of the neuroleptic malignant syndrome. Psychiatr Ann., 2000;30(5):363-374.
43. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore). 1982;61(3):141-152.
44. Marik PE. Rhabdomyolysis. In: Handbook of Evidence-Based Critical Care., New York, NY: Springer; 2010:469-478.
45. Visweswaran P, Guntupalli J. Rhabdomyolysis. Crit Care Clin., 1999; 15(2):415-428.
46. David WS. Myoglobinuria. Neurol Clin., 2000;18(1):215-243.
47. Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med., 1992; 92(5):455-457.
48. Varon J. Practical Guide to the Care of the Critically Ill Patient: Practical Guide Series., St Louis, MO: Mosby; 1994:317-319.
49. Odeh M. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med., 1991;324(20):1417-1422.
50. Zager RA. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest., 1992; 90(3):711-719.
51. Conger JD. Interventions in clinical acute renal failure: what are the data? Am J Kidney Dis., 1995;26(4):565-576.
52. Homsi E, Barreiro MF, Orlando JM, Higa EM. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail., 1997;19(2):283-288.
53. Slater MS, Mullins RJ. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg., 1998;186(6):693-716.
54. Moore KP, Holt SG, Patel RP, et al. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem., 273(48):31731-31737.
55. Ronco C. Extracorporeal therapies in acute rhabdomyolysis and myoglobin clearance. Crit Care., 2005;9(2):141-142
56. Bourke E, Delaney V. Assessment of hypocalcemia and hypercalcemia. Clin Lab Med., 1993;13(1):157-181.